Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
28.9M
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
4.76M
-
Shares change
-
-157K
-
Total reported value, excl. options
-
$93.8M
-
Value change
-
-$3.06M
-
Number of buys
-
34
-
Number of sells
-
-25
-
Price
-
$19.71
Significant Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q1 2021
69 filings reported holding HQL - abrdn Life Sciences Investors - Common Shares, $0.01 par value as of Q1 2021.
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.76M shares
of 28.9M outstanding shares and own 16.49% of the company stock.
Largest 10 shareholders include NEEDHAM INVESTMENT MANAGEMENT LLC (475K shares), Advisors Asset Management, Inc. (419K shares), WELLS FARGO & COMPANY/MN (405K shares), MORGAN STANLEY (396K shares), FLAGSHIP HARBOR ADVISORS, LLC (322K shares), Matisse Capital (319K shares), 1832 Asset Management L.P. (304K shares), LAZARD ASSET MANAGEMENT LLC (204K shares), COHEN & STEERS, INC. (166K shares), and 1607 Capital Partners, LLC (160K shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.